Related references
Note: Only part of the references are listed.Cancer statistics, 2022
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2022)
Yuanhuacin and Related Anti-Inflammatory and Anticancer Daphnane Diterpenes from Genkwa Flos-An Overview
Christian Bailly
BIOMOLECULES (2022)
Targeting the p53-MDM2 pathway for neuroblastoma therapy: Rays of hope
Atif Zafar et al.
CANCER LETTERS (2021)
Targeting metastatic cancer
Karuna Ganesh et al.
NATURE MEDICINE (2021)
Up-Regulation of LINC00665 Facilitates the Malignant Progression of Prostate Cancer by Epigenetically Silencing KLF2 Through EZH2 and LSD1
Peng Xue et al.
FRONTIERS IN ONCOLOGY (2021)
The Most Competent Plant-Derived Natural Products for Targeting Apoptosis in Cancer Therapy
Sadegh Rajabi et al.
BIOMOLECULES (2021)
Downregulation of LINC00665 suppresses the progression of lung adenocarcinoma via regulating miR-181c-5p/ZIC2 axis
Wei Wei et al.
Aging-US (2021)
Yuanhuacine Is a Potent and Selective Inhibitor of the Basal-Like 2 Subtype of Triple Negative Breast Cancer with Immunogenic Potential
Charles S. Fermaintt et al.
CANCERS (2021)
Cancer incidence, mortality, and burden in China: a time-trend analysis and comparison with the United States and United Kingdom based on the global epidemiological data released in 2020
Haibo Qiu et al.
CANCER COMMUNICATIONS (2021)
Micropeptide CIP2A-BP encoded by LINC00665 inhibits triple-negative breast cancer progression
Binbin Guo et al.
EMBO JOURNAL (2020)
Novel therapeutic targets for cancer metastasis
Konstantin Stoletov et al.
EXPERT REVIEW OF ANTICANCER THERAPY (2020)
Gain-of-function mutant p53 in cancer progression and therapy
Cen Zhang et al.
JOURNAL OF MOLECULAR CELL BIOLOGY (2020)
Prostate Cancer Incidence and Survival, by Stage and Race/Ethnicity — United States, 2001–2017
David A. Siegel et al.
MMWR-MORBIDITY AND MORTALITY WEEKLY REPORT (2020)
Global, Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2017 A Systematic Analysis for the Global Burden of Disease Study
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2019)
Anti-Cancer Natural Products and Their Bioactive Compounds Inducing ER Stress-Mediated Apoptosis: A Review
Changmin Kim et al.
NUTRIENTS (2018)
Targeting metastasis-initiating cells through the fatty acid receptor CD36
Gloria Pascual et al.
NATURE (2017)
The Diagnosis and Treatment of Prostate Cancer A Review
Mark S. Litwin et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2017)
Targeting the MDM2-p53 Protein-Protein Interaction for New Cancer Therapy: Progress and Challenges
Shaomeng Wang et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Daphnane and Phorbol Diterpenes, Anti-neuroinflammatory Compounds with Nurr1 Activation from the Roots and Stems of Daphne genkwa
Baek-Soo Han et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2017)
Long Noncoding RNA and Cancer: A New Paradigm
Arunoday Bhan et al.
CANCER RESEARCH (2017)
Daphnane Diterpenes from Daphne genkwa Activate Nurr1 and Have a Neuroprotective Effect in an Animal Model of Parkinson's Disease
Baek-Soo Han et al.
JOURNAL OF NATURAL PRODUCTS (2016)
Anti-Tumor Activity of Yuanhuacine by Regulating AMPK/mTOR Signaling Pathway and Actin Cytoskeleton Organization in Non-Small Cell Lung Cancer Cells
Ji In Kang et al.
PLOS ONE (2015)
The Chinese Herb Isolate Yuanhuacine (YHL-14) Induces G2/M Arrest in Human Cancer Cells by Up-regulating p21 Protein Expression through an p53 Protein-independent Cascade
Ruowen Zhang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2014)
Daphnane Diterpene Esters with Anti-proliferative Activities against Human Lung Cancer Cells from Daphne genkwa
Ji-Young Hong et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2010)